Loading clinical trials...

NATURE 3.1_New Approach for the Reduction of REnal Uremic Toxins | Clinical Trials | Clareo Health

COMPLETEDNANCT03815786

NATURE 3.1_New Approach for the Reduction of REnal Uremic Toxins

The objective of the pilot study is to validate the clinical use of an innovative symbiotic in patients with chronic kidney disease (CKD) stage 3b-4 and in healthy subjects. The study aims at evaluat...

Lead sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls

NCT06631261 · Bronchiectasis Adult, Healthy Controls Group - Age and Sex-matched

RECRUITING

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

NCT06474169 · Chronic Kidney Diseases

RECRUITINGPhase 1

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

NCT07258836 · Neoplasms, Healthy

RECRUITINGPhase 1

A Study of Eltrekibart (LY3041658) in Healthy Participants

NCT07545590 · Healthy

RECRUITING

Collection of Data and Samples From Healthy Donors for Use in Translational Research

NCT00090662 · Healthy Volunteer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 15, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment50

Start dateMay 2017

Last updatedFeb 15, 2022

Condition

Chronic Kidney Diseases Healthy

Locations shown

AUO Policlinico Consorziale

Bari, BA

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 15, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

NATURE 3.1_New Approach for the Reduction of REnal Uremic Toxins

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

A Study of Eltrekibart (LY3041658) in Healthy Participants

Collection of Data and Samples From Healthy Donors for Use in Translational Research

Trial snapshot

Condition

Locations shown

For caregivers